Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Study Finds Racial Differences in Cure Rates for Hepatitis C

In a large ethnically diverse group of patients seen at a community-based Veterans Affairs practice, cure rates for chronic hepatitis C were lower for African American individuals relative to White individuals, even when patients were receiving optimal therapies.

Thursday, February 22, 2018 12:01 am EST

In a large ethnically diverse group of patients seen at a community-based Veterans Affairs practice, cure rates for chronic hepatitis C were lower for African American individuals relative to White individuals, even when patients were receiving optimal therapies. The findings are published in Pharmacology Research & Perspectives.

The investigators noted that although the results demonstrate the importance of racial/ethnic differences in chronic hepatitis C, the true causes of these differences remain unclear and should be further explored in prospective studies where drug levels and patient genetics are taken into account.


Additional Information

Link to Study: http://doi.wiley.com/10.1002/prp2.379

About Journal

Pharmacology Research & Perspectives (PR&P) is a collaboration between the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS) and Wiley. PR&Pis an open access journal that publishes original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, education and related research areas.

Multimedia Files:

Preview image

Contact:

Penny Smith
+44 (0) 1243 770448
sciencenewsroom@wiley.com

Business Wire NewsHQsm